Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mm's could be slowly buying cheapies for someone who is doing an equity deal. Imho
I believe it was J&J.
That's a cheap amplifier not a hearing aid.
Time to buy.
Normal retrace imho
bowmo™, Inc., a New York City–based HR-Tech company (“bowmo™,” “the Company”), is pleased to announce the execution of the Agreement and Plan of Merger (“Agreement”) with Cruzani, Inc. (CZNI), an OTC fully reporting company.
A licencing agreement or equity deal will start the domino effect, absolutely no doubt. Imho
Bid .0006
Ask .0008
Dr. Chandra holds a Master of Business Administration(MBA)degree so he definitely knows something about business besides being a great physician, surgeon and scientist.
I'm It is better that it is manipulated because with such terribly low volume it would probably just tank.
"All milestones will be met"
NDA=Silence
I appreciate all you do especially to help some of us who otherwise would have absolutely no clue how to project or estimate the value of a company.
Is that estimate based on an equity deal? And would the estimated pps be achieved shortly after an equity announcement?
So, bigtalan, does that mean there is no NDA and the law suits are why they are silent. And also why they are w/o the audit completed??
I agree. I was just completing the biological process. Lol
The last stage of metamorphosis is painful as it struggles to break the cacoon and become free to fly ??
ENZC>Regereron>Roche>EMA>FDA Reciprocal agreement>Worldwide distribution.
Roche said on "it would focus on its other COVID-19 products including antibody cocktail Ronapreve, developed in partnership with Regeneron (REGN.O)"
https://www.reuters.cobm/business/healthcare-pharmaceuticals/atea-pharma-says-deal-develop-covid-19-pill-with-roche-terminated-2021-11-16/
https://www.fiercepharma.com/pharma/covid-19-antibody-cocktail-from-regeneron-roche-slashes-hospitalizations-and-tackles
#John Rim #Roche #Reuters #Regn #Samsung
IPF is not a med and it is not subject to approval. Only drugs are subject to approval. IPF Immune is a dietary food supplement registered with the FDA, reg. 1083. We are OK here. Harry did his homework. Dietary food supplements are dealt with differently than drugs.They require registration with the FDA. After that they are required to complete a lengthy computer generated form with data to indicate that the product is safe for human consumption. The form must be submitted to the FDA at least 75 days before the product enters into interstate commerce. According to the FDA some companies in the past have not followed the 75 day ruling and the FDA did not do anything about it.
Now, on May 19, all of a sudden the FDA announces that they are temporarily enforcing the 75 day ruling and also that dietary supplements can be subject to inspection. If they don't find discrepancies they can hold the shipment no more than 30 days. However, if they suspect noncompliance they can pull representative samples for testing which can take weeks. They also indicated that they will be checking labels, company websites, and social media for false claims.
Again, it is very unusual to see this "temporary" action during the same timeframe that IPF Immune entered the US. This is the first time since 1994 that FDA has tightened requirements for dietary supplements. IMHO
As I see it, there could be multiple deals in the mix with ENZC Roche and GILD in the submerged iceburg. On a side note, GILD has worked with Roche in the past, licensing their Tamiflu to Roche. Another yet plausible deal with ENZC and Roche is with diagnostics. Their diagnostic headquarters is in Warsaw Poland and is quite impressive. "Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics. We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies. We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers. We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably. We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries. We are a force of over 90,000 people working together across more than 100 countries."
https://ichgcp.net/pharma-list/office/120-roche
Keep your ear to the ground for Roche(Europe) and its fully owned subsidiary Genentech. GILD developed Tamiflu and licensed it to Roche some years ago. The Tamiflu patent has been expired for some time and the generic Oseltamivir form of Tamiflu is available with a script. So, Roche is not generating the nice profits from Tamiflu anymore. An interesting observation is that John Rim-, CEO of Samsung worked in upper management for both Roche and Genentech for many years before going with Samsung. It is expected that ITV-1 will be seeking EMA approval. With Rim's knowledge of Tamiflu and prior association with Roche and Genentech, might there be the possibility of some kind of deal involving IPF and or ITV-1? Is that why IPF was halted in the US and the NDA was extended?? This is my one message that I am allowed today.
/status/1539027237541847040?t=oft_gjJaVtgbyxdGxJRllQ&s=19
Although none of us know for sure exactly what will be revealed with the termination of the NDA(s) the reason why IPF Immune was halted remains a mystery. Here is some food for thought ( It is my THOUGHTS that usually get me in trouble lol)
John Rim~
CEO, EVP
Samsung Biologics 2018-present
Roche-Global Product Development
2010-2018
Genentech(subsidiary of Roche)
2004-2010
The point is that executives often build on their past connections and experiences. It is interesting to note that the Swiss based Roche produces Tamiflu. Enzolytics IPF Immune will be its strong competitor. Consider also that ITV-1 is a suspension of IPF and will be seeking EMA approval.
Connect the dots.?? Again, just my opinion.
Tom tweeted something very nice! $ENZC https://t.co/nezo3cmLRc
— ENZC LONG(ER) 😂 (@EnzcLonger) June 13, 2022
Read Gilead's Core Values and Mission. "Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next."
Only Enzolytics can continue their dream. Because Enzolytics Is what's next. So, is there a balm in Gilead?
My permitted post of the day.
Gilead.com
Reversal in progress. $$$
Just remember that there is a balm in Gilead.
Mutat, I greatly appreciate and enjoy your posts and of course your great attitude and outlook. That's my only post for the day. God bless.
.
Some people just trying to drive the pps down to get super cheapies. Alot of flippers these days. Know what you own.
Imported dietary supplements are subject to FDA inspection when arriving at any port of entry. The FDA may hold or seize shipments that do not comply with U.S. regulations. It is imperative to follow all rules prescribed by the FDA.Jan 21, 2022
Charles was also CEO of Bioclonetics for 8 1/2 years. This is not his first rodeo.
Seems odd indeed that just when Enzolytics begins to introduce IPF in the US market, the FDA all of a sudden changes it's policy on the acceptance of NDI's. This is nothing but an orchestrated strategy to protect Tamiflu sales and prevent the sales of IPF Immune in the US.
https://www.fda.gov/food/cfsan-constituent-updates/fda-releases-draft-guidance-ndi-enforcement-discretion
So, Mutat, does it still mean 6 months to a year? Or could we see an equity deal or something else big in the meantime?
Maga, I agree. Keep up the good work.
$1 new car, $3 new house. Hold the rest.
No. They are not confused. I am a former FDA Consumer Safety Officer. There has to be an FDA clearance. One problem may be that the individual retail package may not declare the country of origin.
Total agree Cat.
I believe you are spot on Holygrail.
I have to agree. I don't see manipulation. I just see low volume and no earth shaking news, thus the continued downward trend. There could very well be one or multiple NDA's in the mix which would be the part of the iceberg that we do not see. It is exciting to know that once the dam breaks the dominoes will fall in succession. I believe we are very close. Go ENZC
Spot on Holygrail.
And the CEO sounded so sincere.